RBM10 modulation of circRNA biogenesis contributes to its tumor suppressor role in lung adenocarcinoma.
Saved in:
| Title: | RBM10 modulation of circRNA biogenesis contributes to its tumor suppressor role in lung adenocarcinoma. |
|---|---|
| Authors: | Utrilla-Maestre A; Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain.; GENYO. Centre for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain., Matia-González AM; Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain.; GENYO. Centre for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain., Peinado P; Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain.; GENYO. Centre for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.; The Francis Crick Institute, London, UK., Becerra-Rodriguez MA; Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain.; GENYO. Centre for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, Granada, Spain., Benitez-Cantos MS; GENYO. Centre for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.; Department of Biochemistry and Molecular Biology III, Faculty of Medicine, University of Granada, Granada, Spain., Cuadros M; GENYO. Centre for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.; Department of Biochemistry and Molecular Biology III, Faculty of Medicine, University of Granada, Granada, Spain., Medina PP; Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain. pedromedina@ugr.es.; GENYO. Centre for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, Granada, Spain. pedromedina@ugr.es.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain. pedromedina@ugr.es. |
| Source: | Biomarker research [Biomark Res] 2026 Feb 12; Vol. 14 (1), pp. 24. Date of Electronic Publication: 2026 Feb 12. |
| Publication Type: | Letter |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101607860 Publication Model: Electronic Cited Medium: Print ISSN: 2050-7771 (Print) Linking ISSN: 20507771 NLM ISO Abbreviation: Biomark Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
